Spot-on use. For external use only.
Posology
The recommended minimum doses are 14.4 mg tigolaner / kg body weight, 3 mg emodepside / kg body weight, 12 mg praziquantel / kg body weight equivalent to 0.148 ml product / kg body weight.
Body Weight of Cat (Kg) | Applicator size to be used: Felpreva spot-on solution | Volume of unit (ml) | Tigolaner (mg/kg bw) | Emodepside (mg/kg bw) | Praziquantel (mg/kg bw) |
1.0 - 2.5 | for small cats | 0.37 | 14.5 - 36.2 | 3.0 - 7.5 | 12.0 - 30.1 |
2.6 - 5.0 | for medium cats | 0.74 | 14.5 - 27.9 | 3.0 - 5.8 | 12.0 - 23.2 |
5.1 - 8.0 | for large cats | 1.18 | 14.4 - 22.7 | 3.0 - 4.7 | 12.0 - 18.8 |
>8.0 | Use an appropriate combination of applicators |
Treatment schedule
Treatment is only indicated when ectoparasites, cestodes and nematodes are targeted at the same time. In the absence of mixed infections or risk of mixed infections, appropriate narrow spectrum antiparasitic products should be used.
Fleas and ticks
The veterinary medicinal product remains active against fleas and ticks for a period of 13 weeks.
If re-treatment is necessary within 13 weeks after administration, an appropriate narrow-spectrum product should be used.
Mites
For the treatment of ear mites (Otodectes cynotis) and notoedric mange (Notoedres cati) a single dose of the veterinary medicinal product should be administered.
The treatment success and the need for re-treatment with an appropriate narrow-spectrum antiparasitic product should be determined by the treating veterinarian after 4 weeks.
Due to individual cases of single surviving ear mites and, therefore, the risk of a new cycle of otocariosis, the treatment success should be confirmed by the veterinarian 1 month after treatment.
Gastrointestinal nematodes and tapeworms
For the treatment of roundworms and tapeworms a single dose of the veterinary medicinal product should be administered. The need for and frequency of re-treatment should be in accordance with the advice of the prescribing veterinarian and take into account the local epidemiological situation as well as the cat’s lifestyle.
If a re-treatment is necessary within 3 months after administration, an appropriate narrow-spectrum product should be used.
Lungworms
For treatment against the lungworm Aelurostrongylus abstrusus and Troglostrongylus brevior, one treatment with the product followed by a second treatment two weeks apart with a spot-on solution for cats containing 21.4 mg/ml emodepside and 85.8 mg/ml praziquantel is recommended as there is no veterinary medicinal product containing only emodepside as active substance.
Method of administration
Use scissors (1) to open the childproof blister. Pull foils apart (2) and remove spot-on applicator from package (3).
Hold applicator in upright position (4), twist and pull off cap (5) and use the opposite end of the cap to break the seal (6).
Part the fur on the cat’s neck at the base of the skull until the skin is visible (7). Place the tip of the applicator on the skin and squeeze firmly several times to empty the contents directly onto the skin (7). Application on the base of the skull will minimise the ability of the cat to lick the product off.